Latest news releases from NIH-funded organizations

Funded Research News

Updates every hour. Last Updated: 15-May-2025 06:10 ET (15-May-2025 10:10 GMT/UTC)

6-Jan-2025

As prevention strategy for sexually transmitted infections rolls out, experts highlight both promise and knowledge gaps

NIH/National Institute of Allergy and Infectious Diseases
Peer-Reviewed Publication

DoxyPEP is reducing the rate of syphilis and chlamydia but has had little to no effect on gonorrhea and needs close monitoring for antibiotic resistance.

Journal

JAMA Internal Medicine

Funder

NIH/National Institute of Allergy and Infectious Diseases

6-Jan-2025

Lighting up cancer cells with biolasers

Michigan Medicine - University of Michigan
Peer-Reviewed Publication

Researchers from the University of Michigan have developed a way of detecting circulating tumor cells in the bloodstream of pancreatic cancer and lung cancer patients.

Journal

Biosensors and Bioelectronics

Funder

NIH/National Institutes of Health, Judith Tam ALK Lung Cancer Research Initiative, LUNGevity Foundation, Breast Cancer Research Foundation

6-Jan-2025

Floods linked to rise in US deaths from several major causes

Columbia University's Mailman School of Public Health
Peer-Reviewed Publication

Over the last 20 years, large floods were associated with up to 24.9 percent higher death rates from major mortality causes in the U.S. compared to normal conditions. A new study in the journal Nature Medicine demonstrates the sweeping and hidden effects of floods—including floods unrelated to hurricanes, such as those due to heavy rain, snowmelt, or ice jams.

Journal

Nature Medicine

Funder

NIH/National Institute of Environmental Health Sciences

5-Jan-2025

Study uncovers key role of enzyme G6PC2 in controlling blood sugar by regulating glucagon secretion

The Hebrew University of Jerusalem
Peer-Reviewed Publication

New study shows that the gene G6PC2 plays an important role in regulating glucagon, a hormone that raises blood sugar levels. It helps set the point at which blood sugar levels stop glucagon from being released. This finding is especially important for type 2 diabetes (T2D), where high glucagon levels make it harder to control blood sugar. By uncovering how G6PC2 regulates glucagon release from pancreatic alpha cells, in addition to its established role in regulating insulin secretion from pancreatic beta cells, the research points to a new potential treatment that could target both glucagon, and insulin to better manage blood sugar.

Journal

Science Translational Medicine

Funder

NIH/National Institutes of Health, Ruth L. Kirschstein, National Research Service Award (NRSA), U.S-Israel Binational Science Foundation, Israel Science Foundation, Juvenile Diabetes Research Foundation in Israel

3-Jan-2025

Scientists unveil surprising human vs mouse differences in a major cancer immunotherapy target

University of California - San Diego
Peer-Reviewed Publication

Much of our knowledge of the protein PD-1, a leading cancer treatment target, comes from studies in mice. In a comprehensive assessment of PD-1, researchers have found that PD-1 in mice is significantly weaker than the human version, providing new information on how cancer treatments are developed.

Journal

Science Immunology

Funder

NIH/National Institutes of Health, Human Frontier Science Program, Japan Science and Technology Agency, American Cancer Society, Hartwell Foundation, Kinship Foundation, Pew Charitable Trusts